Literature DB >> 10749583

Detection of TNFalpha expression in the bone marrow and determination of TNFalpha production of peripheral blood mononuclear cells in myelodysplastic syndrome.

L Molnár1, T Berki, A Hussain, P Németh, H Losonczy.   

Abstract

TNFalpha is a highly active cytokine which plays an important role in the regulation of apoptotic cell death, a mechanism involved in the pathophysiology of myelodysplastic syndrome (MDS). In this study we investigated the expression of TNFalpha of the bone marrow trephine biopsies by immunohistochemical method and the TNFalpha production of peripheral blood mononuclear cells by ELISA method in 15 patients affected by MDS. Five of seven patients without excess of blasts showed high or intermediate TNFalpha expression in the bone marrow biopsies, whereas two patients with excess of blasts were negative and one had low expression. The five CMML patients revealed low or intermediate expression. The production of TNFalpha by the PBMC was analysed in 10 patients, four patients with RA and two with CMML produced higher level of TNFalpha which increased after stimulation with phorbol myristic acetate, but none of the RAEB patients revealed increase in TNFalpha production. In conclusion we suppose that increased TNFalpha expression and production by PBMC may be an indirect evidence of the role of increased apoptosis in low risk MDS patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749583     DOI: 10.1007/bf03032653

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  27 in total

Review 1.  Apoptosis and its significance in MDS: controversies revisited.

Authors:  Y Yoshida; G J Mufti
Journal:  Leuk Res       Date:  1999-09       Impact factor: 3.156

Review 2.  The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells.

Authors:  D Metcalf
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-alpha concentration.

Authors:  C M Peddie; C R Wolf; L I McLellan; A R Collins; D T Bowen
Journal:  Br J Haematol       Date:  1997-12       Impact factor: 6.998

4.  Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in 'good' versus 'poor' prognosis patients and correlation with apoptosis-related genes.

Authors:  P Tsoplou; A Kouraklis-Symeonidis; E Thanopoulou; P Zikos; V Orphanos; N C Zoumbos
Journal:  Leukemia       Date:  1999-10       Impact factor: 11.528

5.  A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.

Authors:  G M Gersuk; C Beckham; M R Loken; P Kiener; J E Anderson; A Farrand; A B Troutt; J A Ledbetter; H J Deeg
Journal:  Br J Haematol       Date:  1998-10       Impact factor: 6.998

6.  Impairment of GM-CSF production in myelodysplastic syndromes.

Authors:  G Visani; G Zauli; P Tosi; M Fogli; A Cenacchi; C Finelli; B Gamberi; E Ottaviani; S Manfoi; S Tura
Journal:  Br J Haematol       Date:  1993-06       Impact factor: 6.998

7.  Prognostic relevance of transforming growth factor alpha (TGF-alpha) and tumor necrosis factor alpha (TNF-alpha) detected in breast cancer tissues by immunohistochemistry.

Authors:  Z Bebök; B Márkus; P Németh
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Measurement of serum cytokine levels in patients with myelodysplastic syndromes.

Authors:  G E Verhoef; P De Schouwer; J L Ceuppens; J Van Damme; W Goossens; M A Boogaerts
Journal:  Leukemia       Date:  1992-12       Impact factor: 11.528

9.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.

Authors:  J Maciejewski; C Selleri; S Anderson; N S Young
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

10.  Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes.

Authors:  K Ogata; H Tamura; N Yokose; E An; K Dan; H Hamaguchi; H Sakamaki; Y Onozawa; S C Clark; T Nomura
Journal:  Br J Haematol       Date:  1995-05       Impact factor: 6.998

View more
  14 in total

1.  Myelodysplastic syndrome.

Authors:  Shinji Nakao; H Joachim Deeg; Takayuki Ishikawa; Judith Marsh; Alan List; Masao Tomonaga
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

Review 2.  Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success.

Authors:  Elaine M Sloand; A J Barrett
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

3.  Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome.

Authors:  Krishnan Allampallam; Vilasini Shetty; Suneel Mundle; Diya Dutt; Howard Kravitz; Poluru L Reddy; Sairah Alvi; Naomi Galili; Gurveen S Saberwal; Shalini Anthwal; Maliha W Shaikh; Aaron York; Azra Raza
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

4.  Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS.

Authors:  A Mario Marcondes; Aravind Ramakrishnan; H Joachim Deeg
Journal:  Curr Cancer Ther Rev       Date:  2009-11-01

5.  RNPS1 inhibits excessive tumor necrosis factor/tumor necrosis factor receptor signaling to support hematopoiesis in mice.

Authors:  Xue Zhong; Jin Huk Choi; Sara Hildebrand; Sara Ludwig; Jianhui Wang; Evan Nair-Gill; Tzu-Chieh Liao; James J Moresco; Aijie Liu; Jiexia Quan; Qihua Sun; Duanwu Zhang; Xiaoming Zhan; Mihwa Choi; Xiaohong Li; Junmei Wang; Thomas Gallagher; Eva Marie Y Moresco; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-28       Impact factor: 12.779

6.  Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.

Authors:  A Mario Marcondes; Andrew J Mhyre; Derek L Stirewalt; Soo-Hyun Kim; Charles A Dinarello; H Joachim Deeg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

7.  Tumor necrosis factor and its receptors in the neuroretina and retinal vasculature after ischemia-reperfusion injury in the pig retina.

Authors:  Bodil Gesslein; Gisela Håkansson; Lotta Gustafsson; Per Ekström; Malin Malmsjö
Journal:  Mol Vis       Date:  2010-11-06       Impact factor: 2.367

8.  Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.

Authors:  Andrew Volk; Jing Li; Junping Xin; Dewen You; Jun Zhang; Xinli Liu; Yechen Xiao; Peter Breslin; Zejuan Li; Wei Wei; Rachel Schmidt; Xingyu Li; Zhou Zhang; Paul C Kuo; Sucha Nand; Jianke Zhang; Jianjun Chen; Jiwang Zhang
Journal:  J Exp Med       Date:  2014-05-19       Impact factor: 14.307

Review 9.  Bone Marrow Immunity and Myelodysplasia.

Authors:  Claude Lambert; Yuenv Wu; Carmen Aanei
Journal:  Front Oncol       Date:  2016-07-20       Impact factor: 6.244

Review 10.  Signal transduction inhibitors in treatment of myelodysplastic syndromes.

Authors:  Lohith Bachegowda; Oleg Gligich; Ionnis Mantzaris; Carolina Schinke; Dale Wyville; Tatiana Carrillo; Ira Braunschweig; Ulrich Steidl; Amit Verma
Journal:  J Hematol Oncol       Date:  2013-07-10       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.